PERT Consortium Marks 2,000-Patient Milestone in Quality Registry

August 15, 2019—The PERT Consortium of pulmonary embolism (PE) response teams announced that its quality database has recorded more than 2,000 unique patient episodes at the two dozen sites across the United States that are entering data into the registry.

According to the PERT Consortium, the prospective, multicenter quality registry is recording outcomes on all patients with PE who were assessed, triaged, and managed by team-based care across the United States. Initiated in 2019 in partnership with the Boston Clinical Research Institute, the registry allows for real-time assessment of outcomes for patients with acute PE. Each participating site receives quarterly feedback in the form of a quality dashboard to review the outcomes for their patients and compare their outcomes with the rest of the nation.

Robert Lookstein, MD, who serves as Vice President of the PERT Consortium, commented to Endovascular Today, “This is an incredible milestone for our organization. We are thrilled to see so much enthusiasm from our member sites to contribute to this important quality registry for the care of patients with PE.” Dr. Lookstein is Professor of Radiology and Surgery and Executive Vice Chairman of the Department of Diagnostic, Molecular, and Interventional Radiology at the Icahn School of Medicine at Mount Sinai in New York, New York.

Kenneth Rosenfield, MD, Immediate Past-President of the PERT Consortium, added, "The PERT Consortium quality assurance and research database represents a powerful tool that will define quality for management of PE and enable sites to improve on PE care by benchmarking their performance. Working with Michael Gibson and his team at at Boston Clinical Research Institute, the PERT Registry will provide a rich source of data to enable a better understanding of clinical and pathophysiologic aspects of PE, as well as treatment outcomes. Finally, and perhaps most compelling, is the opportunity (enthusiastically supported by both the FDA and industry) to perform prospective research on therapies for PE, utilizing the registry as a backbone. Every institution managing PE should join this important PE registry and begin to track their outcomes and quality." Dr. Rosenfield is Section Head, Vascular Medicine and Intervention, and Chairman, STEMI & Acute MI Quality Improvement Committee, at Massachusetts General Hospital in Boston, Massachusetts.

On October 4–5, 2019, the PERT Consortium’s 5th annual Pulmonary Embolism Symposium will be held in Boston, Massachusetts. The 2-day meeting is designed for practicing clinicians who regularly care for patients with PE, as well as those who are interested in studying the pathophysiology, epidemiology, diagnosis, medical and interventional management, novel treatment paradigms, and outcomes of PE.

More about PE response teams can be learned in the July 2019 supplement to Endovascular Today, which is sponsored by the PERT Consortium.